FDA Inspection 1063706 — Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. on Aug 3, 2018 in Fuzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 3, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fuzhou (China)